Description
Anti-TEM7R Antibody, Non-Fucosylated (BioBet-1580ZP) is a human monoclonal IgG antibody against Tumor endothelial marker 7-related precursor. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Cancer
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Tumor endothelial marker 7-related precursor antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
PLXDC2
Full Name
PLXDC2; plexin domain containing 2; TEM7R; plexin domain-containing protein 2; 1200007L24Rik; tumor endothelial marker 7-related protein;
Background
plexin domain containing 2
Gene ID
84898
Cellular Localization
Membrane
Involvement in Disease
Diseases associated with PLXDC2 include Vulva Cancer and Vulva Squamous Cell Carcinoma.
Function
May play a role in tumor angiogenesis.
Post-translational modifications
1.Glycosylation at Ser86, Asn103, Asn160, Asn316, and Asn345 2.Modification sites at PhosphoSitePlus
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
BioBet-1580ZP
Description
The antibody specifically bind to an epitope on the extracellular domain of TEM7R, and may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.
Antibody Indication
Cancer
